Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Genetics

Free Subscription Articles published in J Natl Cancer Inst Retrieve available abstracts of 17 articles: HTML format

Single Articles

January 2026
1. WANG S, Rao Z, Blaes AH, Coresh J, et al
   Proteomic aging clocks and the risk of mortality among long-term cancer survivors.
   J Natl Cancer Inst. 2026;118:102-112.
   PubMed     Abstract available
   
   
   November 2025
2. RIPPERGER T, Kratz CP
   A cancer predisposition screening tool for young adults with cancer.
   J Natl Cancer Inst. 2025;117:2163-2168.
   PubMed     Abstract available
   
   
   July 2025
3. SYLEOUNI ME, Joshu CE, Coresh J, Gunter MJ, et al
   Discovering plasma proteins associated with breast cancer incidence in post-menopausal women in ARIC.
   J Natl Cancer Inst. 2025 Jul 7:djaf170. doi: 10.1093.
   PubMed     Abstract available
   
   
   April 2025
4. DEBORTOLI E, McGahan E, Yanes T, Berkman J, et al
   Utility of genomic testing in children, adolescents, and young adults with cancer.
   J Natl Cancer Inst. 2025;117:601-610.
   PubMed     Abstract available
   
   
   January 2025
5. STACKLAND S, Schnabel D, Dinan MA, Presley CJ, et al
   Strength of evidence underlying the CMS-FDA parallel review of comprehensive genomic profiling tests in the cancer setting.
   J Natl Cancer Inst. 2025;117:144-151.
   PubMed     Abstract available
   
   
   
6. GOGLIA AG, Alshalalfa M, Khan A, Isakov DR, et al
   Pan-cancer genomic analysis reveals FOXA1 amplification is associated with adverse outcomes in non-small cell lung, prostate, and breast cancers.
   J Natl Cancer Inst. 2025;117:188-197.
   PubMed     Abstract available
   
   
   December 2024
7. DAS D, Wang X, Chiu YC, Bouamar H, et al
   Integrative multi-omics characterization of hepatocellular carcinoma in Hispanic patients.
   J Natl Cancer Inst. 2024;116:1961-1978.
   PubMed     Abstract available
   
   
   November 2024
8. MIRZA MB, Choi J, Marincola Smith P, Baechle JJ, et al
   ERBB2 amplification in gastric cancer: a genomic insight into ethnic disparities.
   J Natl Cancer Inst. 2024;116:1830-1833.
   PubMed     Abstract available
   
   
   September 2024
9. KEANE F, Chou JF, Walch H, Schoenfeld J, et al
   Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease.
   J Natl Cancer Inst. 2024;116:1429-1438.
   PubMed     Abstract available
   
   
   August 2024
10. ZHANG X, Zhao L, Ngo LH, Dillon ST, et al
    Prediagnostic plasma proteomics profile for hepatocellular carcinoma.
    J Natl Cancer Inst. 2024;116:1343-1355.
    PubMed     Abstract available
    
    
    May 2024
11. JONES CM, Karp J, Davis DS
    Genomic testing and patient rights.
    J Natl Cancer Inst. 2024;116:771-772.
    PubMed    
    
    
    April 2024
12. SUN J, Luo J, Jiang F, Zhao J, et al
    Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers.
    J Natl Cancer Inst. 2024;116:565-573.
    PubMed     Abstract available
    
    
    February 2024
13. BASU A, Rais-Bahrami S
    Genomic risk scores in prostate cancer: polygenic yes, but are they poly-ancestral?
    J Natl Cancer Inst. 2024 Feb 16:djae025. doi: 10.1093.
    PubMed    
    
    
    
14. MEERNIK C, Raveendran Y, Kolarova M, Rahman F, et al
    Racial and ethnic disparities in genomic testing among lung cancer patients: a systematic review.
    J Natl Cancer Inst. 2024 Feb 6:djae026. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2023
15. HUEY RW, Shah AT, Reddi HV, Dasari P, et al
    Feasibility and value of genomic profiling in cancer of unknown primary: real-world evidence from prospective profiling study.
    J Natl Cancer Inst. 2023;115:994-997.
    PubMed     Abstract available
    
    
    
16. WANG H, Ding XH, Liu CL, Xiao Y, et al
    Genomic alterations impacting tumor-infiltrating lymphocytes and PD-L1 expression patterns in triple-negative breast cancer.
    J Natl Cancer Inst. 2023 Aug 7:djad154. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2023
17. FENG X, Wu WY, Onwuka JU, Haider Z, et al
    Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools.
    J Natl Cancer Inst. 2023 Jun 1:djad071. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Genetics is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum